1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
QuasarEdge Acquisition Corp, a special purpose acquisition company listed on the NYSE, signed a merger agreement with Robseek Intelligence Inc., a Cayman Islands AI technology company. The Company's shareholders would receive 100,000,000 shares of the post-merger listed company, valued at $10.00 per share, based on a pre-money equity valuation of $1 billion, and the deal remains subject to shareholder and SEC approvals and other closing conditions.
Pre-money equity valuation of Robseek set at $1,000,000,000; 100,000,000 Purchaser ordinary shares valued at $10.00 per share
Immediately after closing, Purchaser's board is expected to have seven directors: one designated by QuasarEdge and six by Robseek
Closing requires shareholder approvals, SEC effectiveness of the registration statement, and stock exchange listing approval
Certain shareholders are expected to sign lock-up agreements restricting transfers for 180 days after closing
Casey's reported fourth-quarter diluted EPS of $4.37, up from $2.63 a year earlier, with net income of $162.7 million, driven by higher inside and fuel gross profit. For fiscal 2026, diluted EPS was $19.16 and EBITDA was nearly $1.5 billion, and the company guided fiscal 2027 EBITDA growth of 8% to 10%. The board also expanded the share repurchase authorization to $1 billion from $400 million, which bears directly on shareholder returns.
Q4 fiscal 2026 diluted EPS $4.37, up 66.2%; net income $162.7 million, up 65.5%
Fiscal 2026 diluted EPS $19.16, up 30.9%; net income $714.4 million, up 30.7%
Share repurchase authorization expanded to $1 billion from $400 million, effective June 4, 2026
Quarterly dividend raised 14% to $0.65 per share, payable August 14, 2026
On June 8, 2026, Ingredion agreed with Tate & Lyle's board on a recommended all-cash acquisition of Tate & Lyle at 595 pence per share, with cash consideration of about £2.7 billion (about $3.6 billion) and an implied enterprise value of about $5.0 billion. Ingredion plans to fund the deal with existing cash, new debt and, if needed, a 364-day bridge loan, and expects pro forma net leverage of about 3.0x net debt-to-adjusted EBITDA at completion. The deal is expected to close in the second half of 2027, subject to Tate & Lyle shareholder and court approval and antitrust conditions, and Ingredion expects it to be adjusted EPS accretive in the first year.
Tate & Lyle shareholders would receive 595 pence in cash per share, about a 59% premium to the May 13, 2026 closing price.
Cash consideration is about £2.7 billion (about $3.6 billion); implied enterprise value is about £3.7 billion ($5.0 billion).
Ingredion expects pro forma net leverage of about 3.0x at completion and about 2.5x within about 18 months.
Expected run-rate net cost synergies of about $130 million by the end of 2030, against one-time costs of about $175 million.
Cracker Barrel reported fiscal third-quarter 2026 revenue of $797.4 million, down 2.9% from a year earlier, and GAAP diluted earnings of $1.90 per share, which include a $47.4 million litigation settlement benefit. Excluding non-GAAP adjustments, adjusted diluted earnings were $0.29 per share versus $0.58 a year earlier, and adjusted EBITDA was $40.3 million versus $48.1 million. The company raised its fiscal 2026 revenue and adjusted EBITDA outlook, which is the main positive for shareholders.
Q3 total revenue $797.4 million, down 2.9%; comparable store restaurant sales down 2.6%
GAAP diluted EPS $1.90 vs $0.56; adjusted diluted EPS $0.29 vs $0.58
Fiscal 2026 adjusted EBITDA outlook raised to $120 million to $125 million from $85 million to $100 million
Fiscal 2026 revenue outlook raised to $3.27 billion to $3.30 billion from $3.24 billion to $3.27 billion
Matan Fattal resigned as a director and from the Audit, Compensation, and Nominating and Corporate Governance committees, effective June 5, 2026, and the filing says the resignation was not due to any disagreement with the company or its board. Following his departure, the company notified Nasdaq that it no longer meets audit committee and board independence requirements, and it intends to rely on cure periods while it searches for an independent director.
Matan Fattal resigned as director and from three board committees, effective June 5, 2026.
On June 8, 2026, the company notified Nasdaq that its audit committee no longer meets the three-member, independent-director requirement under Rule 5605(c)(2)(A).
The board now has two independent directors, two non-independent directors, and one vacant seat, so it no longer has an independent majority, a temporary noncompliance under Rule 5605(b).
The company intends to use Nasdaq cure periods and is searching for an independent director to join the board and audit committee.
Grocery Outlet appointed Ian Ferry as Executive Vice President, Chief Financial Officer and Treasurer, effective June 9, 2026, succeeding Christopher Miller, who leaves June 26, 2026. The company also named Paul Miller Executive Vice President, Chief Purchasing and Merchandising Officer, replacing Matthew Delly, who departs June 12, 2026, and affirmed its second quarter and fiscal 2026 outlook first provided May 13, 2026. The finance and purchasing leadership changes matter to shareholders because they reshape two senior roles, while the outlook was reaffirmed rather than changed.
Ian Ferry, 45, joined in June 2025 and becomes CFO with a $475,000 base salary and a target bonus of 60% of base salary.
Christopher Miller's departure is effective June 26, 2026; Matthew Delly's is effective June 12, 2026.
Paul Miller, a former Grocery Outlet executive who retired in 2024, returns full-time after serving as an advisor.
Susan Leary was promoted to Senior Vice President, Accounting and designated Principal Accounting Officer, with a $300,000 base salary.
CECO Environmental issued an initial full year 2026 outlook for the combined company after closing its acquisition of Thermon Group Holdings on June 1, 2026. The company expects revenue of $1.275 billion to $1.375 billion and Adjusted EBITDA of $195 million to $225 million, with guidance including seven months of Thermon contribution. Both measures are projected to rise about 20% and 25%, respectively, at the midpoints compared with the prior year.
Thermon acquisition closed June 1, 2026; guidance includes June through December contribution from Thermon.
Full year 2026 revenue expected between $1.275 billion and $1.375 billion, up about 20% at the midpoint year over year.
Adjusted EBITDA expected between $195 million and $225 million, up about 25% at the midpoint; free cash flow expected to be at least 55% of Adjusted EBITDA.
Management remains confident in generating $40 million or more in cost synergies.
Cibus, Inc. appointed Craig Wichner, a director since November 2025 and founder of Farmland LP, as Chief Executive Officer effective June 8, 2026, ending Peter Beetham's interim CEO role that began in February 2025. Both Wichner and Beetham resigned from the Board, and the authorized number of directors was reduced to seven. The filing discloses Wichner's pay package and a cut to Beetham's 2026 base salary, but it contains no financial results or guidance.
Wichner's employment agreement sets a base salary of $650,000, plus a discretionary annual bonus and annual incentive equity award.
Wichner received a restricted stock unit award and a stock option award, each with a grant date fair value of $1,100,000, vesting 25% annually over four years.
Beetham's 2026 base salary was reduced from $650,000 to $585,000 given his change in role.
Wichner's standard severance is 18 months of base salary; under a change in control it is 24 months.
Academy Sports and Outdoors reported first-quarter fiscal 2026 net sales of $1.44 billion, up 6.7%, and GAAP diluted EPS of $0.80, up 17.6%. The company raised the low end of its full-year guidance, lifting GAAP diluted EPS to $5.95 to $6.35 from $5.65 to $6.15, which benefits shareholders while management says it expects inflationary pressures to continue weighing on consumer spending.
Q1 net sales of $1.44 billion, up 6.7%; comparable sales up 2.9%
Q1 GAAP diluted EPS of $0.80, up 17.6%; adjusted diluted EPS of $0.93, up 22.4%
FY2026 GAAP diluted EPS guidance raised to $5.95-$6.35 from $5.65-$6.15; adjusted EPS guidance raised to $6.40-$6.80 from $6.10-$6.60
Quarterly dividend of $0.15 per share declared June 4, 2026, payable July 16, 2026 to holders of record on June 18, 2026
Quanterix appointed Jason Faessler as Chief Financial Officer and Treasurer, with employment expected to begin June 22, 2026. He previously led global FP&A and the Americas finance organization at Bruker Corporation, and the filing sets out his pay and severance terms.
Employment agreement dated May 31, 2026 provides an initial annualized base salary of $475,000 and a cash sign-on bonus of $200,000.
Annual bonus target of up to 50% of base salary.
Restricted stock units equal to 0.30% of common shares outstanding on his start date, vesting in four equal annual installments.
Severance includes 12 months of base salary and a pro-rated target bonus; full equity vesting applies if the termination is tied to a change in control.
J.M. Smucker reported fourth-quarter fiscal 2026 net sales of $2.3 billion, up 6%, and adjusted earnings per share of $2.77, up 20%. For the full fiscal year, adjusted EPS fell 10% to $9.15 and the company posted a net loss of $1.30 per diluted share, while it guided fiscal 2027 net sales down 3.0% to 4.0% and adjusted EPS of $9.75 to $10.25.
Q4 net sales $2.3 billion (about $2,268.1 million), up 6%; adjusted EPS $2.77 vs. $2.31 a year earlier.
Q4 GAAP net income $3.64 per diluted share, compared with a net loss of $6.85 in the prior-year quarter, which included $867.3 million of goodwill impairment charges.
Fiscal 2026 net sales $9.1 billion, up 4%; net loss of $1.30 per diluted share; adjusted EPS $9.15, down 10%.
Fiscal 2027 outlook: net sales down 3.0% to 4.0%, adjusted EPS $9.75 to $10.25, free cash flow about $1.0 billion.
Novanta agreed on June 8, 2026 to acquire Riverpoint Medical from Arlington Capital Partners for $1.2 billion in cash at closing, plus a $250 million milestone payment due by January 8, 2027. The deal is funded with cash on hand, existing credit facilities and a $300 million equity raise, and the credit agreement was amended to raise the permitted leverage ratio, which means more debt for shareholders to carry. The company expects the deal to close in the third quarter of 2026 and says it will update guidance after closing.
Purchase price of $1.2 billion in cash at closing, subject to customary adjustments, plus a $250 million milestone payment due on or before January 8, 2027
Financing from cash on hand, existing credit facilities and a recently completed $300 million equity raise
Credit agreement amended: permitted consolidated leverage ratio raised to 4.00 to 1.00, or 4.50 to 1.00 for four quarters after a designated acquisition
Expected net leverage of about 2.7x at closing in the third quarter of 2026, with a target below 2.3x by year-end 2027; standalone 2026 guidance was confirmed
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.